(3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium and 1,2-dielaidoylphosphatidylethanolamine

(3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium has been researched along with 1,2-dielaidoylphosphatidylethanolamine in 15 studies

Compound Research Comparison

Studies ((3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium)	Trials ((3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium)	Recent Studies (post-2010) ((3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium)	Studies (1,2-dielaidoylphosphatidylethanolamine)	Trials (1,2-dielaidoylphosphatidylethanolamine)	Recent Studies (post-2010) (1,2-dielaidoylphosphatidylethanolamine)
52	3	1	625	1	72

Research

Studies (15)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	12 (80.00)	18.2507
2000's	3 (20.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fasbender, AJ; Moninger, T; Poellinger, KA; Welsh, MJ; Zabner, J	1
Felgner, JH; Felgner, PL; Gao, X; Jaffe, ML; Plautz, GE; Pompili, VJ; San, H; Wheeler, CJ; Xu, L; Yang, ZY	1
Cheng, SH; Felgner, PL; Manthorpe, M; Marshall, J; Sukhu, L; Tsai, YJ; Wheeler, CJ	1
Curiel, TJ; Felgner, PL; Harrison, GS; Hogan, C; Shpall, EJ; Tomczak, J; Wang, Y	1
Bustamente, C; Felgner, P; Manthorpe, M; Norman, J; Sukhu, L; Tsai, Y; Wheeler, CJ; Yang, G	1
Düzgüneş, N; Felgner, PL; Konopka, K; Pretzer, E	1
Felgner, PL; Hanisch, UK; Reszka, R; Zhang, L; Zhu, J	1
Carmel, J; Felgner, PL; Haas, M; Hsiao, M; Silverberg, GD; Tsai, Y; Tse, V	1
Barnfield, C; Gao, L; Klavinskis, LS; Lehner, T; Parker, S	1
El Ouahabi, A; Fuks, R; Pector, V; Ruysschaert, JM; Thiry, M; Vandenbranden, M	1
Barenholz, Y; Zuidam, NJ	1
Flechsler, I; Jung, G; Surovoy, A	1
Abul-Hassan, K; Boulton, M; Walmsley, R	1
Bednarz, J; Dannowski, H; Engelmann, K; Pleyer, U; Reszka, R	1
Bianco, A; Cametti, C; Esposito, C; Grosso, ND; Malizia, D; Masotti, A; Mossa, G; Ortaggi, G	1

Reviews

1 review(s) available for (3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium and 1,2-dielaidoylphosphatidylethanolamine

Article	Year
Improved cationic lipid formulations for in vivo gene therapy. Annals of the New York Academy of Sciences, 1995, Nov-27, Volume: 772 Topics: Animals; beta-Galactosidase; Cation Exchange Resins; Cations; Chloramphenicol O-Acetyltransferase; DNA, Recombinant; Dodecanol; Drug Administration Routes; Drug Carriers; Genes, Reporter; Genetic Therapy; Genetic Vectors; Lipids; Liposomes; Luciferases; Macromolecular Substances; Mice; Mice, Inbred BALB C; Myristic Acids; Phosphatidylethanolamines; Quaternary Ammonium Compounds; Recombinant Fusion Proteins; Transfection	1995

Article

Year

Improved cationic lipid formulations for in vivo gene therapy.

Annals of the New York Academy of Sciences, 1995, Nov-27, Volume: 772

Topics: Animals; beta-Galactosidase; Cation Exchange Resins; Cations; Chloramphenicol O-Acetyltransferase; DNA, Recombinant; Dodecanol; Drug Administration Routes; Drug Carriers; Genes, Reporter; Genetic Therapy; Genetic Vectors; Lipids; Liposomes; Luciferases; Macromolecular Substances; Mice; Mice, Inbred BALB C; Myristic Acids; Phosphatidylethanolamines; Quaternary Ammonium Compounds; Recombinant Fusion Proteins; Transfection

1995

Other Studies

14 other study(ies) available for (3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium and 1,2-dielaidoylphosphatidylethanolamine

Article	Year
Cellular and molecular barriers to gene transfer by a cationic lipid. The Journal of biological chemistry, 1995, Aug-11, Volume: 270, Issue:32 Topics: Cell Nucleus; DNA; Gene Transfer Techniques; HeLa Cells; Humans; Lipids; Myristic Acids; Phosphatidylethanolamines; Quaternary Ammonium Compounds; Transcription, Genetic; Transfection	1995
Safety and short-term toxicity of a novel cationic lipid formulation for human gene therapy. Human gene therapy, 1993, Volume: 4, Issue:6 Topics: Animals; Cations; Female; Genetic Therapy; Genetic Vectors; Heart; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Lipids; Liposomes; Mice; Mice, Inbred BALB C; Myristic Acids; Organ Specificity; Phosphatidylethanolamines; Quaternary Ammonium Compounds; Swine; Transfection	1993
Optimization of gene transfer using cationic lipids in cell lines and primary human CD4+ and CD34+ hematopoietic cells. BioTechniques, 1995, Volume: 19, Issue:5 Topics: Animals; Antigens, CD34; Cations; CD4-Positive T-Lymphocytes; Cell Line; DNA; Gene Expression; Gene Transfer Techniques; Genes, Reporter; Genetic Techniques; Genetic Vectors; Hematopoietic Stem Cells; Humans; Lipid Metabolism; Lipids; Luciferases; Lymphoma; Mice; Phosphatidylethanolamines; Quaternary Ammonium Compounds; Spermine; Tumor Cells, Cultured	1995
Converting an alcohol to an amine in a cationic lipid dramatically alters the co-lipid requirement, cellular transfection activity and the ultrastructure of DNA-cytofectin complexes. Biochimica et biophysica acta, 1996, Apr-03, Volume: 1280, Issue:1 Topics: Alcohols; Amines; Animals; beta 2-Microglobulin; beta-Galactosidase; Cell Line; DNA; Drug Carriers; Genes, Bacterial; Genes, MHC Class I; HLA-B7 Antigen; Humans; Lipids; Liposomes; Phosphatidylethanolamines; Plasmids; Quaternary Ammonium Compounds; Recombinant Proteins; Structure-Activity Relationship; Transfection; Tumor Cells, Cultured	1996
Human immunodeficiency virus type-1 (HIV-1) infection increases the sensitivity of macrophages and THP-1 cells to cytotoxicity by cationic liposomes. Biochimica et biophysica acta, 1996, Jul-24, Volume: 1312, Issue:3 Topics: Animals; Cation Exchange Resins; Cattle; Cell Line; Cell Survival; Cells, Cultured; Culture Media; HIV Seronegativity; HIV-1; Humans; In Vitro Techniques; Lipids; Liposomes; Macrophages; Monocytes; Phosphatidylethanolamines; Quaternary Ammonium Compounds; Tetradecanoylphorbol Acetate; Virion; Virus Replication	1996
A continuous intracerebral gene delivery system for in vivo liposome-mediated gene therapy. Gene therapy, 1996, Volume: 3, Issue:6 Topics: Animals; Antiviral Agents; Brain Neoplasms; Cell Survival; DNA, Viral; Ganciclovir; Gene Transfer Techniques; Genes, Reporter; Genetic Therapy; Glioma; Humans; Lac Operon; Lipids; Liposomes; Phosphatidylethanolamines; Quaternary Ammonium Compounds; Rats; Rats, Inbred F344; Simplexvirus; Stereotaxic Techniques; Thymidine Kinase	1996
Intracavitary liposome-mediated p53 gene transfer into glioblastoma with endogenous wild-type p53 in vivo results in tumor suppression and long-term survival. Biochemical and biophysical research communications, 1997, Apr-17, Volume: 233, Issue:2 Topics: Animals; Brain Neoplasms; Drug Delivery Systems; Gene Transfer Techniques; Genetic Therapy; Glioblastoma; Humans; Lipids; Liposomes; Mice; Mice, Nude; Phosphatidylethanolamines; Quaternary Ammonium Compounds; Rats; Tumor Cells, Cultured; Tumor Suppressor Protein p53	1997
Mucosal immunization with DNA-liposome complexes. Vaccine, 1997, Volume: 15, Issue:8 Topics: Administration, Intranasal; AIDS Vaccines; Animals; DNA, Viral; Enzyme-Linked Immunosorbent Assay; Female; HIV Antibodies; HIV-1; Immunity, Mucosal; Lipids; Liposomes; Mice; Phosphatidylethanolamines; Quaternary Ammonium Compounds; T-Lymphocytes; T-Lymphocytes, Cytotoxic; Vaccines, DNA	1997
The role of endosome destabilizing activity in the gene transfer process mediated by cationic lipids. FEBS letters, 1997, Sep-08, Volume: 414, Issue:2 Topics: Amidines; Animals; Cell Membrane; Chloramphenicol O-Acetyltransferase; COS Cells; Cytomegalovirus; Endosomes; Lipids; Liposomes; Phosphatidylethanolamines; Plasmids; Quaternary Ammonium Compounds; Recombinant Fusion Proteins; Transfection	1997
Electrostatic parameters of cationic liposomes commonly used for gene delivery as determined by 4-heptadecyl-7-hydroxycoumarin. Biochimica et biophysica acta, 1997, Oct-23, Volume: 1329, Issue:2 Topics: Cholesterol; Chromatography, High Pressure Liquid; Fatty Acids, Monounsaturated; Fluorescent Dyes; Gene Transfer Techniques; Hydrogen-Ion Concentration; Kinetics; Lipids; Liposomes; Models, Structural; Molecular Conformation; Phosphatidylcholines; Phosphatidylethanolamines; Quaternary Ammonium Compounds; Static Electricity; Structure-Activity Relationship; Surface Properties; Umbelliferones	1997
A novel series of serum-resistant lipoaminoacid compounds for cellular delivery of plasmid DNA. Advances in experimental medicine and biology, 1998, Volume: 451 Topics: Amino Acids; Cholesterol; Fatty Acids, Monounsaturated; Genetic Vectors; HeLa Cells; Humans; Indicators and Reagents; K562 Cells; Lipids; Luciferases; Phosphatidylethanolamines; Plasmids; Quaternary Ammonium Compounds; Recombinant Proteins	1998
Optimization of non-viral gene transfer to human primary retinal pigment epithelial cells. Current eye research, 2000, Volume: 20, Issue:5 Topics: Aged; Calcium Phosphates; Cation Exchange Resins; DEAE-Dextran; DNA; Dose-Response Relationship, Drug; Flow Cytometry; Gene Expression; Genetic Vectors; Green Fluorescent Proteins; Humans; Lipids; Liposomes; Luciferases; Luminescent Proteins; Middle Aged; Phosphatidylethanolamines; Pigment Epithelium of Eye; Quaternary Ammonium Compounds; Time Factors; Transfection	2000
Lipid-mediated gene transfer of acidic fibroblast growth factor into human corneal endothelial cells. Experimental eye research, 2005, Volume: 80, Issue:1 Topics: Blotting, Western; Cell Count; Cell Division; Cells, Cultured; Cholesterol; Endothelial Cells; Endothelium, Corneal; Fibroblast Growth Factor 1; Flow Cytometry; Genetic Vectors; Humans; Lipids; Liposomes; Microscopy, Electron; Phosphatidylethanolamines; Quaternary Ammonium Compounds; Transfection	2005
Comparison of different commercially available cationic liposome-DNA lipoplexes: Parameters influencing toxicity and transfection efficiency. Colloids and surfaces. B, Biointerfaces, 2009, Feb-01, Volume: 68, Issue:2 Topics: Animals; Cations; Cell Death; Cell Line, Tumor; Cell Survival; Cholesterol; DNA; Lipids; Liposomes; Particle Size; Phosphatidylethanolamines; Quaternary Ammonium Compounds; Rats; Serum; Time Factors; Transfection	2009